Barkowski, Scott (2021): Physician Response to Prices of Other Physicians: Evidence from a Field Experiment.
Preview |
PDF
MPRA_paper_108966.pdf Download (797kB) | Preview |
Abstract
Recent efforts to increase price transparency for American consumers of health care have largely failed to produce savings. Medical-field research on physician-side price transparency, however, has shown promise for savings but suffers from pervasive methodological problems. I perform a field experiment that addresses these measurement difficulties while studying an area that has received little attention: physician referrals. Working with a group of medical practices linked as an Independent Practice Association (IPA), I randomly selected primary care practices to receive a list of average costs -- that is, prices -- for new referrals to six ophthalmology practices that were part of the IPA's provider network. These practices handled the bulk of the IPA's ophthalmology patients and represented substitute providers. Using the IPA's administrative data on referrals, I find that during the first two months following the distribution of the price list, the treatment group primary care physicians (PCPs) increased referral share towards the least expensive ophthalmology practice by 147 percent. These referrals were allocated away from the most expensive practice and those not listed on the report. These effects were only found, however, for patients for whom the PCPs had a cost reduction incentive. The large initial effect dissipated over the following four months. For patients with a limited financial interest for the PCPs, I find little evidence of a treatment response. These contrasting results suggest the PCPs were influenced by cost reduction motives and provide more evidence of the potential for savings from physician-side price transparency.
Item Type: | MPRA Paper |
---|---|
Original Title: | Physician Response to Prices of Other Physicians: Evidence from a Field Experiment |
Language: | English |
Keywords: | Physician price transparency; referrals; information |
Subjects: | D - Microeconomics > D8 - Information, Knowledge, and Uncertainty > D83 - Search ; Learning ; Information and Knowledge ; Communication ; Belief ; Unawareness I - Health, Education, and Welfare > I1 - Health > I11 - Analysis of Health Care Markets |
Item ID: | 108966 |
Depositing User: | Scott Barkowski |
Date Deposited: | 03 Aug 2021 00:45 |
Last Modified: | 03 Aug 2021 00:45 |
References: | Allan, G. Michael and Grant D. Innes, “Do family physicians know the costs of medical care? Survey in British Columbia.,” Canadian Family Physician, 2004, 50 (2), 263–270. Allan, G. Michael and Joel Lexchin, “Physician awareness of diagnostic and nondrug therapeutic costs: A systematic review,” International Journal of Technology Assessment in Health Care, April 2008, 24 (02), 158–165. Allan, G. Michael, Joel Lexchin, and Natasha Wiebe, “Physician awareness of drug cost: a systematic review,” PLoS medicine, 2007, 4 (9). Anthony, Denise, “Changing the nature of physician referral relationships in the US: the impact of managed care,” Social Science & Medicine, 2003, 56 (10), 2033–2044. Barnett, Michael L., Nancy L. Keating, Nicholas A. Christakis, A. James O’Malley, and Bruce E. Landon, “Reasons for Choice of Referral Physician Among Primary Care and Specialist Physicians,” Journal of General Internal Medicine, May 2012, 27 (5), 506–512. Bates, David W., Gilad J. Kuperman, Ashish Jha, Jonathan M. Teich, E. John Orav, Nell Ma’luf, Andrew Onderdonk, Robert Pugatch, Donald Wybenga, James Winkelman, Troyen A. Brennan, Anthony L. Komaro., and Milenko J. Tanasijevic, “Does the computerized display of charges a.ect impatient ancillary test utilization?,” Archives of Internal Medicine, November 1997, 157 (21), 2501 – 2508. Brotman, Daniel J., Leonard S. Feldman, and Kenneth M. Shermock, “Impact of Displaying Inpatient Pharmaceutical Costs at the Time of Order Entry: Lessons From a Tertiary Care Center,” Journal of Hospital Medicine, August 2017, 12 (8), 639–645. Chien, Alyna T., Lisa Soleymani Lehmann, Laura A. Hat.eld, Kate E. Koplan, Carter R. Petty, Anna D. Sinaiko, Meredith B. Rosenthal, and Thomas D. Sequist, “A Randomized Trial of Displaying Paid Price Information on Imaging Study and Procedure Ordering Rates,” Journal of General Internal Medicine, April 2017, 32 (4), 434–448. Cummings, K. Michael, Kenneth B. Frisof, Michael J. Long, and George Hrynkiewich, “The Effects of Price Information on Physicians’ Test-Ordering Behavior: Ordering of Diagnostic Tests,” Medical Care, 1982, 20 (3), 293–301. Desai, Sunita, Laura A. Hat.eld, Andrew L. Hicks, Anna D. Sinaiko, Michael E. Chernew, David Cowling, Santosh Gautam, Sze jung Wu, and Ateev Mehrotra, “Offering A Price Transparency Tool Did Not Reduce Overall Spending Among California Public Employees And Retirees,” Health A.airs, August 2017, 36 (8), 1401–1407. Desai, Sunita, Laura A. Hat.eld, Andrew L. Hicks, Anna D. Sinaiko, Michael E. Chernew, David Cowling, Santosh Gautam, Sze jung Wu, and Ateev Mehrotra, Michael E. Chernew, and Ateev Mehrotra, “Association Between Availability of a Price Transparency Tool and Outpatient Spending,” JAMA, May 2016, 315 (17), 1874. Donohoe, Martin T., Richard L. Kravitz, David B. Wheeler, Ravi Chandra, Alice Chen, and Natasha Humphries, “Reasons for outpatient referrals from generalists to specialists,” Journal of General Internal Medicine, May 1999, 14 (5), 281–286. Durand, Daniel J., Leonard S. Feldman, Jonathan S. Lewin, and Daniel J. Brotman, “Provider Cost Transparency Alone Has No Impact on Inpatient Imaging Utilization,” JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY, 2013, 10 (2), 108–113. Feldman, Leonard S., Hasan M. Shihab, David Thiemann, Hsin-Chieh Yeh, Margaret Ardolino, Steven Mandell, and Daniel J. Brotman, “Impact of providing fee data on laboratory test ordering: A controlled clinical trial,” JAMA Internal Medicine, April 2013, pp. 1–6. Forrest, Christopher B. and Robert J. Reid, “Prevalence of health problems and primary care physicians’ specialty referral decisions,” Journal of family practice, 2001, 50 (5), 427–427. Forrest, Christopher B., Gordon B. Glade, Alison E. Baker, Alison B. Bocian, Myungsa Kang, and Barbara Star.eld, “The pediatric primary-specialty care interface: How pediatricians refer children and adolescents to specialty care,” Archives of Pediatrics & Adolescent Medicine, July 1999, 153 (7), 705–714. Forrest, Christopher B., Paul A. Nutting, Barbara Starfield, and Sarah Von Schrader, “Family physicians’ referral decisions: results from the ASPN referral study.,” Journal of Family Practice, 2002, 51 (3), 215–223. Forrest, Christopher B., Paul A. Nutting, Sarah von Schrader, Charles Rohde, and Barbara Star.eld, “Primary care physician specialty referral decision making: patient, physician, and health care system determinants,” Medical decision making: an international journal of the Society for Medical Decision Making, February 2006, 26 (1), 76–85. Frazier, Linda M., J. Trig Brown, George W. Divine, Gayle R. Fleming, Nancy M. Philips, William C. Siegal, and Moise A. Khayrallah, “Can Physician Education Lower the Cost of Prescription Drugs?,” Annals of Internal Medicine, July 1991, 115 (2), 116. Galen, Benjamin T., “The Impact of Cost Displays on Ordering,” Journal of General Internal Medicine, October 2014, 29 (10), 1331–1331. Goetz, Celine, Stephen R. Rotman, George Hartoularos, and Tara F. Bishop, “The E.ect of Charge Display on Cost of Care and Physician Practice Behaviors: A Systematic Review,” Journal of General Internal Medicine, June 2015, 30 (6), 835–842. Gourevitch, Rebecca A., Sunita Desai, Andrew L. Hicks, Laura A. Hat.eld, Michael E. Chernew, and Ateev Mehrotra, “Who Uses a Price Transparency Tool? Implications for Increasing Consumer Engagement,” INQUIRY: The Journal of Health Care Organization, Provision, and Financing, 2017, 54, 1–5. Hackl, Franz, Michael Hummer, and Gerald J. Pruckner, “Old boys’ network in general practitioners’ referral behavior?,” Journal of Health Economics, September 2015, 43, 56–73. Hampers, Louis C., Susie Cha, David J. Gutglass, Steven E. Krug, and Helen J. Binns, “The E.ect of Price Information on Test-ordering Behavior and Patient Outcomes in a Pediatric Emergency Department,” Pediatrics, April 1999, 103 (Supplement 1), 877. 2 Ho, Kate and Ariel Pakes, “Hospital Choices, Hospital Prices, and Financial Incentives to Physicians,” American Economic Review, December 2014, 104 (12), 3841–3884. Horn, Daniel M., Kate E. Koplan, Margaret D. Senese, E. John Orav, and Thomas D. Sequist, “The Impact of Cost Displays on Primary Care Physician Laboratory Test Ordering,” Journal of General Internal Medicine, May 2014, 29 (5), 708–714. Kinchen, Kraig S., Lisa A. Cooper, David Levine, Nae Yuh Wang, and Neil R. Powe, “Referral of Patients to Specialists: Factors A.ecting Choice of Specialist by Primary Care Physicians,” Annals of Family Medicine, May 2004, 2 (3), 245–252. Kozak, Patrick M., Silas P. Trumbo, Bradley W. Christensen, David L. Leverenz, Matthew S. Shotwell, and Adam J. Kingeter, “Addition of price transparency to an education and feedback intervention reduces utilization of inpatient echocardiography by resident physicians,” The International Journal of Cardiovascular Imaging, July 2019, 35 (7), 1259–1263. Kyle, Margaret K. and David B. Ridley, “Would Greater Transparency And Uniformity Of Health Care Prices Bene.t Poor Patients?,” Health A.airs, September 2007, 26 (5), 1384–1391. Luhby, Tami, “Trump signs executive order requiring hospitals to disclose prices to patients | CNN Politics,” June 2019. Luhby, Tami, “Trump’s hospital price transparency rule now in e.ect. Here’s what that means.,” January 2021. 1 Marton, Keith I., Viviana Tul, and Harold C. Sox Jr., “Modifying test-ordering behavior in the outpatient medical clinic: A controlled trial of two educational interventions,” Archives of Internal Medicine, May 1985, 145 (5), 816–821. Melendez-Rosado, Jose, Kristine M. Thompson, Jed C. Cowdell, Catalina Sanchez Alvarez, Ryan L. Ung, Armando Villanueva, Kayin B. Je.ers, Jaafer S. Imam, Mario V. Mitkov, Tasneem A. Kaleem, Lewis Jacob, and Nancy L. Dawson, “Reducing unnecessary testing: an intervention to improve resident ordering practices,” Postgraduate Medical Journal, August 2017, 93 (1102), 476–479. Publisher: The Fellowship of Postgraduate Medicine Section: Original article. Monsen, Craig B., Joshua M. Liao, Barak Gaster, Kevin J. Flynn, and Thomas H. Payne, “The e.ect of medication cost transparency alerts on prescriber behavior,” Journal of the American Medical Informatics Association, October 2019, 26 (10), 920–927. Mummadi, Srinivas R. and Raghavendra Mishra, “E.ectiveness of provider price display in computerized physician order entry (CPOE) on healthcare quality: a systematic review,” Journal of the American Medical Informatics Association, September 2018, 25 (9), 1228–1239. Okike, Kanu, Robert V. O’Toole, Andrew N. Pollak, Julius A. Bishop, Christopher M. McAndrew, Samir Mehta, William W. Cross, Grant E. Garrigues, Mitchel B. Harris, and Christopher T. Lebrun, “Survey Finds Few Orthopedic Surgeons Know The Costs Of The Devices They Implant,” Health A.airs, January 2014, 33 (1), 103–109. Reichert, Steven, Todd Simon, and Ethan A. Halm, “Physicians’ attitudes about prescribing and knowledge of the costs of common medications,” Archives of Internal Medicine, October 2000, 160 (18), 2799–2803. Riggs, Kevin R. and Matthew DeCamp, “Providing Price Displays for Physicians: Which Price Is Right?,” JAMA, October 2014, 312 (16), 1631. Riley, Jacquelyn D., Glenn Stanley, Robert Wyllie, Kandice Kottke-Marchant, and Gary W. Procop, “The Impact of an Electronic Expensive Test Noti.cation,” American Journal of Clinical Pathology, April 2018, 149 (6), 530–535. Satterthwaite, F. E., “An Approximate Distribution of Estimates of Variance Components,” Biometrics Bulletin, 1946, 2 (6), 110–114. Publisher: [International Biometric Society, Wiley]. Schiavoni, Katherine H., Lisa Soleymani Lehmann, Wendy Guan, Meredith Rosenthal, Thomas D. Sequist, and Alyna T. Chien, “How Primary Care Physicians Integrate Price Information into Clinical Decision-Making,” Journal of General Internal Medicine, January 2017, 32 (1), 81–87. Schmidt, Robert L., Jorie M. Colbert-Getz, Caroline K. Milne, Daniel J. Vargo, Jerry W Hussong, John R. Hoidal, Boaz A. Markewitz, Brandon S. Walker, and Kensaku Kawamoto, “Impact of Laboratory Charge Display Within the Electronic Health Record Across an Entire Academic Medical Center: Results of a Randomized Controlled Trial,” American Journal of Clinical Pathology, November 2017, 148 (6), 513–522. Sedrak, Mina S., Jennifer S. Myers, Dylan S. Small, Irving Nachamkin, Justin B. Ziemba, Dana Murray, Gregory W. Kurtzman, Jingsan Zhu, Wenli Wang, Deborah Mincarelli, Daniel Danoski, Brian P. Wells, Je.rey S. Berns, Patrick J. Brennan, C. William Hanson, C. Jessica Dine, and Mitesh S. Patel, “E.ect of a Price Transparency Intervention in the Electronic Health Record on Clinician Ordering of Inpatient Laboratory Tests: The PRICE Randomized Clinical Trial,” JAMA Internal Medicine, July 2017, 177 (7), 939. Shulkin, David J., “Cost Estimates of Diagnostic Procedures,” New England Journal of Medicine, November 1988, 319 (19), 1291–1291. Silvestri, Mark T., Tasce R. Bongiovanni, Janis G. Glover, and Cary P. Gross, “Impact of price display on provider ordering: A systematic review: Price Display Systematic Review,” Journal of Hospital Medicine, January 2016, 11 (1), 65–76. Silvestri, Mark T., Xiao Xu, Theodore Long, Tasce Bongiovanni, Steven L. Bernstein, Sarwat I. Chaudhry, Julia I. Silvestri, Marilyn Stolar, Erich J. Greene, James D. Dziura, Cary P. Gross, and Harlan M. Krumholz, “Impact of Cost Display on Ordering Patterns for Hospital Laboratory and Imaging Services,” Journal of General Internal Medicine, August 2018, 33 (8), 1268–1275. Sinaiko, Anna D. and Meredith B. Rosenthal, “Increased Price Transparency in Health Care — Challenges and Potential E.ects,” New England Journal of Medicine, March 2011, 364 (10), 891–894. Sinaiko, Anna D. and Meredith B. Rosenthal, “Examining a health care price transparency tool: who uses it, and how they shop for care,” Health A.airs, 2016, 35 (4), 662–670. Starfield, Barbara, Christopher B. Forrest, Paul A. Nutting, and Sarah von Schrader, “Variability in physician referral decisions.,” The Journal of the American Board of Family Practice, November 2002, 15 (6), 473–480. StataCorp, “Stata Statistical Software: Release 12,” 2011. StataCorp,, “Stata Statistical Software: Release 13.1,” 2013. 14 Tierney, William M., Michael E. Miller, and Clement J. McDonald, “The E.ect on Test Ordering of Informing Physicians of the Charges for Outpatient Diagnostic Tests,” New England Journal of Medicine, May 1990, 322 (21), 1499–1504. Tu, Ha T. and Johanna R. Lauer, “Impact of health care price transparency on price variation: the New Hampshire experience,” Technical Report 128, Center for Studying Health System Change, Washington, DC November 2009. U.S. Government Accountability O.ce, “Health Care Price Transparency: Meaningful Price Information Is Di.cult for Consumers to Obtain Prior to Receiving Care,” Report to Congressional Requesters GAO-11-791 September 2011. Varkey, Prathibha, Mohammad H. Murad, Chad Braun, Kristi J.H. Grall, and Vivek Saoji, “A review of cost-e.ectiveness, cost-containment and economics curricula in graduate medical education: Teaching cost-e.ectiveness,” Journal of Evaluation in Clinical Practice, December 2010, 16 (6), 1055– 1062. Whaley, Christopher, Jennifer Schneider Chafen, Sophie Pinkard, Gabriella Kellerman, Dena Bravata, Robert Kocher, and Neeraj Sood, “Association Between Availability of Health Service Prices and Payments for These Services,” JAMA, October 2014, 312 (16), 1670. |
URI: | https://mpra.ub.uni-muenchen.de/id/eprint/108966 |